Skip to content

Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations

Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis: Pilot Trial Using Community-Based Participatory Research

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05219357
Enrollment
92
Registered
2022-02-02
Start date
2021-11-21
Completion date
2022-01-30
Last updated
2022-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric Disorder

Keywords

Ayurveda, Mental Health, Emergencies, Community Based Participatory Research

Brief summary

For patients undergoing a psychiatric crisis, hospitalisation is required. In developing countries specially in sub-urban or rural areas, most patients don't access intensive care. In India, AYUSH system of medical care is widely used, including crisis resolution and community treatment have been widely implemented in various mental health systems. However, evidence to support their effectiveness has remained very low. Present study is designed as community based participatory research, where Ayurveda treatment , a short-term, specialised, crisis intervention is provided by community outreach team.

Interventions

OTHERAyu-Care

Ayurveda treatment modalities includes three parts to manage mental health Satwawajay Chikitsa, Yuktivyapashray and Daivyapashray Chikitsa. It is based on personalised whole person approach.

DRUGUsual-Care

Management strategies includes restraints, emergency medications, behavioral interventions, with a special focus on the pharmacological interventions.

Sponsors

NMP Medical Research Institute
CollaboratorOTHER
Croydon Ayurveda Centre
CollaboratorUNKNOWN
Active Naturals Limited
CollaboratorUNKNOWN
AVP Research Foundation
CollaboratorUNKNOWN
Aarogyam UK
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Presenting with a psychiatric complaint. * Male or female patients at least 18 years of age. * Each patient, or a patient's legal representative (as allowed by local law), must understand the nature of the study and must agree to study enrollment.

Exclusion criteria

* Patients who have delirium or dementia * Prisoners * Pediatric patients * Elderly patients * Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Length of Emergency hospital stayHours spent in the Emergency Department (ED), measured at the index ED visit (Day 0)Length of stay is defined as the time between patient triage and discharge from the emergency department
Brief Symptom InventoryChange from baseline to 48 hours and 7th-days of interventionBrief Symptom Inventory was used to assess self-report of psychological problems and symptom severity

Secondary

MeasureTime frameDescription
The Psychological Outcome Profiles instrumentFrom Baseline to 3rd and 7th-days of interventionTo measure participant-generated outcomes comprising four items on 6 scale (0-5) 0 = not at all affected' to '5 = severely affected.
Agitation Calmness Evaluation Scale (ACES)From Baseline to 48 hours and 7th-days of interventionThe ACES consists of a single item that rates overall agitation at the time of patients observations on 9 scale (1=marked agitation, 4=normal behaviour, 9= unarousable)
Positive and Negative Syndrome Scale;From Baseline to 48 hours and 7th-days of interventionThe tool consists of 5 items: excitement, tension, hostility, being uncooperative, and poor impulse control. Each item is scored on 7-point scale (1=absent, 2=minimal, 3=mild, 4=moderate, 5=moderate severe, 6=severe, and 7=extreme)
Side effectsFrom Index ED visit to 30 daysThe frequency of any side effects or adverse events experienced by individuals to both intervention group on 4 point scale (landing from absent=0 to severe=3)
Medication useFrom Index ED visit to 30 daysDaily doses and classes of medications (e.g. antipsychotics, mood stabilizers, benzodiazepines, etc.) or other treatments or interventions prescribed per individual
Satisfaction with acute careFrom Baseline to 3rd and 7th-days of interventionMeasured on 5-point scale, completed by the participant using the Service Satisfaction Scale 10 (SSS-10), from 1 (No, definitely not) to five (Yes, definitely)
The Kessler Psychological Distress Scale (K10)Change from baseline to 3rd and 7th-days of interventionThe K10 comprises 10 items that rate symptoms along the anxiety-depression spectrum, with a five point Likert response, where one is 'none of the time' to five 'all of the time.

Other

MeasureTime frameDescription
Death by SuicideFrom Index ED visit to 30 daysDeath by suicide within 30 days of the index ED visit

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026